We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How to use a multiphase optimisation strategy (MOST) to evaluate your digital health product.
How to use a factorial randomised controlled trial to evaluate your digital health product.
What happens when you opt to tax (charge VAT on) land and buildings, when you need permission and when to notify HMRC about your decision.
The Medicines and Healthcare products Regulatory Agency (MHRA) approved a maximum dose of up to 7.2mg per week of semaglutide (Wegovy) on 6 January 2026.
Find out when you can use rebated diesel, biodiesel or kerosene in vehicles and other machinery.
Setting alternative objectives to the Water Framework Directive default water body status objectives.
Guidance for centres on making judgements that will support awarding in 2021
Bringing together industry, academia, the third sector and the NHS to tackle healthcare challenges such as dementia, cancer, mental health, obesity and addiction.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).